DOUGLAS HESS: Open Payments
NPI 1679864441 · FARGO, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 20 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $632 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $239 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $113 |
| Janssen Pharmaceuticals, Inc | 3 | $109 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Janssen Scientific Affairs, LLC | 1 | $33 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: Auvelity, INVEGA SUSTENNA, COBENFY, CAPLYTA, Jornay PM, Wegovy, FANAPT, INGREZZA.
Industry payments across ND — which companies pay providers there.
